CRISPR-powered platforms for DNA and RNA detection bring fast, precise, and affordable disease diagnostics to the point of need

Circular infographic showing the CRISPR-Cas diagnostics workflow, from patient sample and DNA/RNA amplification to Cas12/Cas13 detection and readout on a portable device and lateral-flow test strip.

Next-Generation Simple Diagnostics

Our next-generation CRISPR-Cas diagnostic technology brings unprecedented sensitivity and precision to detecting diseases caused by bacteria, viruses, and other pathogens. Using powerful CRISPR enzymes—Cas12a for DNA targets and Cas13 for RNA targets—our system can identify extremely small amounts of genetic material long before symptoms appear. This dual capability allows us to detect a wide range of infectious agents with accuracy that surpasses many traditional laboratory methods. Despite this advanced science, the platform remains simple, rapid, and suitable for use outside conventional labs.

Key Benefits of CasBio’s CRISPR-Cas Diagnostics

for Point-of-Care Testing

  • CasBio CRISPR-Cas detection system demonstrating high sensitivity and specificity for accurate pathogen identification.
  • Rapid pathogen detection using CasBio CRISPR-Cas technology for fast and accurate results.
  • Multiplex CRISPR-Cas detection by CasBio for simultaneous identification of several pathogens
  • User-friendly CasBio CRISPR-Cas system designed for easy operation in clinics, farms, and home settings.
  • CasBio CRISPR-Cas detection system easily adaptable to detect new and emerging diseases, enabling rapid development of diagnostics for unknown pathogens in clinics, farms, and point-of-care settings.
  • asBio CRISPR-Cas detection system demonstrating robust and reliable performance across various conditions, ensuring accurate, sensitive, and reproducible detection of pathogens in clinics, farms, and point-of-care settings.
  • Rapid CRISPR-Cas detection of Disease X, a WHO-designated emerging pathogen, using CasBio portable device for early intervention and disease control.
Multiplex CRISPR-Cas detection using CasBio portable device for rapid multi-pathogen testing.

Power of Multiplexing
One Input, Many Insights

CasBio’s multiplex detection technology identifies several pathogens in a single test — saving time, cost, and sample volume.

By using a range of CRISPR-Cas enzymes, each tuned to a specific target, our system detects multiple diseases at once with exceptional accuracy. This smart pairing reduces cross-reactivity and boosts reliability — especially when distinguishing co-infections or similar illnesses.

CasBio’s portable device for measuring multiplex signals brings this powerful multi-target analysis wherever it’s needed, from clinics to field settings.

Learn more

CasBio brings advanced CRISPR-Cas point-of-care technology to the farm, providing fast and accurate detection of animal diseases on-site. Our innovative tools make early diagnosis simple and effective—supporting healthier herds and better farm management right where it’s needed most.

On-Farm CRISPR Diagnostics

Learn more
CasBio CRISPR-Cas point-of-care device for fast, accurate on-site detection of animal diseases on farms.
Applications of CRISPR-Cas Diagnostics

Wide Applications of CRISPR-Cas Diagnostics

Fast, accurate, and adaptable across many fields

Learn more